The Indian Competition Authority clears structural separation of global pharmaceutical company’s bioscience business into separate new pharmaceutical company (Baxter India / Baxalta India)

CCI clears Baxter-Baxalta merger deal* CCI vide its order dated September 8, 2015 has approved the proposed transfer of Baxter India’s bioscience business and related assets

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Vaish Associates, Advocates (New Delhi)

Quotation

Man Mohan Sharma, The Indian Competition Authority clears structural separation of global pharmaceutical company’s bioscience business into separate new pharmaceutical company (Baxter India / Baxalta India), 8 September 2015, e-Competitions Bulletin September 2015, Art. N° 87760

Visites 30

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues